In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

(2013) David Oldach et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance

(2013) Deborah L Couldwell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic

(2013) Carin Anagrius et al.   PLoS One

O02.4 Persistent/Recurrent Chlamydial Infection Among STD Clinic Patients Treated with CDC-Recommended Therapies

(2013) C M Khosropour et al.   SEXUALLY TRANSMITTED INFECTIONS

In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?

(2012) Daniel Golparian et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled Trial

(2012) Lisa E. Manhart, Catherine W. Gillespie, M. Sylvan Lowens, Christine M. Khosropour, Danny V. Colombara, Matthew R. Golden, Navneet R. Hakhu, Katherine K. Thomas, James P. Hughes, Nicole L. Jensen, Patricia A. Totten   CLINICAL INFECTIOUS DISEASES

Investigating the entire course of telithromycin binding to Escherichia coli ribosomes

(2012) Ourania N. Kostopoulou et al.   NUCLEIC ACIDS RESEARCH

Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects

(2011) J. Gordon Still et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly

(2011) D. Taylor-Robinson et al.   CLINICAL MICROBIOLOGY REVIEWS

Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis

(2010) B. Llano-Sotelo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IsMycoplasma genitaliumin Women the “New Chlamydia?” A Community‐Based Prospective Cohort Study

(2010) Pippa Oakeshott et al.   CLINICAL INFECTIOUS DISEASES

Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical Trial

(2010) J. R. Schwebke et al.   CLINICAL INFECTIOUS DISEASES

Genetic Variation in the Complete MgPa Operon and Its Repetitive Chromosomal Elements in Clinical Strains of Mycoplasma genitalium

(2010) Liang Ma et al.   PLoS One

In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae

(2009) P. M. Roblin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR

(2009) R. Hamasuna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101

(2009) K. B. Waites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages

(2009) S. Lemaire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms

(2009) P. McGhee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Single‐Dose Azithromycin Treatment forMycoplasma genitalium–Positive Urethritis: Best but Not Good Enough

(2009) Jørgen Skov Jensen   CLINICAL INFECTIOUS DISEASES

Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system

(2008) Liang Ma et al.   BMC MICROBIOLOGY

Azithromycin Treatment Failure inMycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance

(2008) Jørgen S. Jensen et al.   CLINICAL INFECTIOUS DISEASES

Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study

(2008) E Jernberg et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Persistence of Mycoplasma genitalium Following Azithromycin Therapy

(2008) Catriona S. Bradshaw et al.   PLoS One

Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial

(2007) E Bjornelius et al.   SEXUALLY TRANSMITTED INFECTIONS